RegisterLogin

STA-1474

CAT: 0804-HY-13752Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-13752Size:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
STA-1474 is an orally active and highly selective HSP90 inhibitor. STA-1474 can trigger tumor cell apoptosis. STA-1474 demonstrates significant antitumor efficacy in spontaneous canine cancer models (e.g., osteosarcoma, thyroid carcinoma) . STA-1474 is promising for research of solid tumors (e.g., osteosarcoma, breast cancer) and HSP90-driven cancers[1][2].
CAS Number
[1118915-78-8]
UNSPSC
12352005
Target
HSP
Related Pathways
Cell Cycle/DNA Damage; Metabolic Enzyme/Protease
Field of Research
Cancer
Smiles
O=C1NN=C(C2=CC(C(C)C)=C(OP(O)(O)=O)C=C2O)N1C3=CC4=C(N(C)C=C4)C=C3
Molecular Formula
C20H21N4O6P
Molecular Weight
444.38
References & Citations
[1]McCleese JK, Bear MD, Fossey SL, Mihalek RM, Foley KP, Ying W, Barsoum J, London CA. The novel HSP90 inhibitor STA-1474 exhibits biologic activity against osteosarcoma cell lines. Int J Cancer. 2009 Dec 15;125 (12) :2792-801.|[2]London CA, et al. Phase I evaluation of STA-1474, a prodrug of the novel HSP90 inhibitor ganetespib, in dogs with spontaneous cancer. PLoS One. 2011;6 (11) :e27018.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
HSP90

Related Products

CatalogName
HY-47888-01PLN-1474
HY-111170STA-9584
HY-117051STA-2842
HY-179572STA-013
HY-136945-01StA-IFN-1
HY-122883-01BC-1471
HY-110145MRS 1477
HY-169018CIB-1476
HY-10444-01R-1479
HY-13524-01AG-1478

Alternative Products

CatalogName
T71426-01STA-1474
MBS3617084-01PLN-1474
8B0526-AATNMDAR2B (Ab-1474) Antibody
A44502-100ULGRIN2B (Ab-1474) Antibody
Y021158Anti-NMDAR2B (Ab-1474)
C21158NMDAR2B (Ab-1474) Conjugated Antibody
A50-Ab3STA pAb3
MBS3603884STA-21
A50-Ab1STA pAb1
A50-Ab4STA pAb4

Popular Products